ArticleBone marrow transplantation2026

Incidence, clinical risk factors, and biomarkers of SOS/VOD following allogeneic HSCT in adults. A real-life study by the Spanish group of HSCT and cell therapy (GETH-TC).

Ariadna Pérez-Martínez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.